Back to news archive

Gradientech achieves CE-IVD approval for the QuickMIC®system

We are thrilled to announce the CE-IVD registration of our QuickMIC® system and its gram-negative panel. Together with the successful results of the clinical study, the QuickMIC system is now ready for the European market. QuickMIC is a class-leading device which provides reliable AST results in 2-4 hours, and is as for now the first ultra-rapid AST system for sepsis approaching the market.

Link to press-release